tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ONO Pharmaceutical’s ONO-1110 Trial: A Potential Game-Changer for Postherpetic Neuralgia
PremiumCompany AnnouncementsONO Pharmaceutical’s ONO-1110 Trial: A Potential Game-Changer for Postherpetic Neuralgia
3M ago
Bristol-Myers Squibb and ONO Pharmaceutical’s Promising Study on Gastric Cancer Treatment
Premium
Company Announcements
Bristol-Myers Squibb and ONO Pharmaceutical’s Promising Study on Gastric Cancer Treatment
3M ago
Bristol-Myers Squibb and ONO Pharmaceutical’s Nivolumab Study: A Market Game-Changer?
Premium
Company Announcements
Bristol-Myers Squibb and ONO Pharmaceutical’s Nivolumab Study: A Market Game-Changer?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100